Skip to content
Research use only — not for human consumptionBatch documentation on requestThird-party tested purityDiscreet EU delivery21+ onlyMade in EuropeResearch use only — not for human consumptionBatch documentation on requestThird-party tested purityDiscreet EU delivery21+ onlyMade in Europe

RUO · 21+ Только для исследовательских целей (RUO). Все товары на этом сайте предназначены исключительно для лабораторных исследований. Они не являются лекарствами, пищевыми добавками или препаратами для употребления человеком или животными и не предназначены для диагностики, лечения или профилактики каких-либо заболеваний. Используя сайт, вы подтверждаете, что вам 21+, и что покупка совершается исключительно для законных лабораторных исследований. Полная политика исследовательского использования

norecipe
CJC-1295 No DAC (5mg) + Ipamorelin (10mg) | Peptide PenResearch use only

CJC-1295 No DAC (5mg) + Ipamorelin (10mg) | Peptide Pen

CJC-1295 (No DAC) is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH 1-29), designed to stimulate the pituitary’s natural growth hormone secretion through transient receptor activation. The “No DAC” means this version does not contain the Drug Affinity Complex modification.

Without DAC: CJC-1295 (No DAC), also known as Mod GRF 1-29, has a short half-life (≈30 minutes) and produces pulsatile, physiological GH release.

With DAC: The DAC modification forms a covalent bond to serum albumin, creating a long-acting analogue with a half-life of ≈6–8 days, used in research on sustained GH exposure.

210,00 €incl. VAT
In stockRUO
1

Discreet EU shipping. Certificate of analysis available on request. Not for human or animal consumption.

Хранение
Store at 2–8 °C. Do not freeze. Shipped with ice packs.
Форма
Предварительно заполненная ручка

CJC-1295 (No DAC) is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH 1-29), designed to stimulate the pituitary’s natural growth hormone secretion through transient receptor activation. The “No DAC” means this version does not contain the Drug Affinity Complex modification. Without DAC: CJC-1295 (No DAC), also known as Mod GRF 1-29, has a short half-life (≈30 minutes) and produces pulsatile, physiological GH release. With DAC: The DAC modification forms a covalent bond to serum albumin, creating a long-acting analogue with a half-life of ≈6–8 days, used in research on sustained GH exposure. Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist that acts synergistically with GHRH analogues. When combined, CJC-1295 (No DAC) and Ipamorelin are studied for their complementary stimulation of the GH axis through independent receptor pathways. Fields of Study Growth hormone secretion studies Metabolic and endocrine regulation Muscle growth and repair Energy and recovery research

Fields of study

  • Growth hormone secretion studies
  • Metabolic and endocrine regulation
  • Muscle growth and repair
  • Energy and recovery research

Похожие соединения

Смотреть все